MMW - Fortschritte der Medizin

, Volume 154, Issue 21, pp 65–71

Was ist wann zu tun?

Erhöhte Leberwerte
ZERTIFIZIERTE FORTBILDUNG-FOLGE 356
  • 34 Downloads

Mehrfach erhöhte Leberwerte, auch im niedrigen Bereich, können klinisch relevant sein und sollten deshalb abgeklärt werden. Von zentraler Bedeutung ist dabei die Anamnese inklusive Medikamentenanamnese. Welche Ursachen in Frage kommen und welche weiteren diagnostischen Schritte Sie je nach Verdachtsdiagnose einleiten müssen, lesen Sie im nachfolgenden Beitrag.

Keywords - Elevated liver enzymes — what to do and when

Liver disease liver enzymes viral hepatitis autoimmune hepatitis 

Literatur

  1. 1.
    Lobstein S et al. Prevalence, aetiology and associated co-morbidities of elevated aminotransferases in agerman cohort of orthopaedic surgery patients. Z Gastroenterol 2008; 46: 415–420.PubMedCrossRefGoogle Scholar
  2. 2.
    Wedemeyer H et al. ALT als Screeningparameter für Lebererkrankungen: eine kritische Evaluation der Evidenz. Z Gastroenterol 2010; 48: 46–55PubMedCrossRefGoogle Scholar
  3. 3.
    Kim HC et al. Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. BMJ. 2004; 328: 983.PubMedCrossRefGoogle Scholar
  4. 4.
    American Gastroenterological Association Medical Position Statement: Evaluation of Liver Chemistry Tests. Gastroenterology 2002; 123: 1364–1366.Google Scholar
  5. 5.
    Green RM et Flamm S. AGA technical review on the evaluation of liver chemistry tests. Gastroenterology 2002; 123: 1367–1384.PubMedCrossRefGoogle Scholar
  6. 6.
    Abdo A et al. Liver abnormalities in celiac disease. Clin Gastroenterol Hepatol 2004; 2: 107–112.PubMedCrossRefGoogle Scholar
  7. 7.
    Rubio-Tapia A et Murray JA. The liver in celiac disease. Hepatology 2007; 46: 1650–1658.PubMedCrossRefGoogle Scholar
  8. 8.
    Byrne J et al.Evidence for liver injury in the setting of obstructive sleep apnea. Annals Hepatol 2012; 11:228–231.Google Scholar
  9. 9.
    Boulton R et al. Subclinical Addison’s disease: a cause of persistent abnormalities in transaminase values. Gastroenterology 1995; 109: 1324–1327.PubMedCrossRefGoogle Scholar
  10. 10.
    Skelly MM et al. Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology. J Hepatol 2001; 35: 195–199.PubMedCrossRefGoogle Scholar
  11. 11.
    Whitehead MW et al. The causes of obvious jaundice in South West Wales: perceptions versus reality. Gut 2001; 48: 409–413.PubMedCrossRefGoogle Scholar
  12. 12.
    Kamar N et al. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis E virus infection. Gastroenterology. 2010; 139: 1612-1618.Google Scholar
  13. 13.
    Wichmann O et al. Phylogenetic and case-control study on hepatitis E virus infection in Germany. J Infect Dis. 2008;198:1732–1741.PubMedCrossRefGoogle Scholar
  14. 14.
    Hennes EM et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008; 48:169–176.PubMedCrossRefGoogle Scholar
  15. 15.
    Meier Y et al. Incidence of drug-induced liver injury in medical inpatients. Eur J Clin Pharmacol. 2005;61:135–143.PubMedCrossRefGoogle Scholar
  16. 16.
    Andrade RJ et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 2005;129:512–521.PubMedGoogle Scholar

Copyright information

© Urban & Vogel 2012

Authors and Affiliations

  1. 1.Chefarzt Innere Medizin I Klinikum Freising GmbHFreisingDeutschland

Personalised recommendations